Home » Topics » Regulatory » Patents

Patents
RSS

Cleveland Clinic Foundation creates novel anti-CD6 antibodies

Jan. 9, 2018

Jiangsu Chia Tai Tianqing Pharmaceutical Group and others patent JAK2 inhibitors

Jan. 9, 2018

Cadent Therapeutics discovers new potassium channel modulators

Jan. 8, 2018

Rice University presents novel thailanstatin A derivatives

Jan. 8, 2018

New farnesoid X receptor modulators identified at Gilead

Jan. 8, 2018

Institute of Organic Chemistry and Biochemistry and others patent 17-beta-HSD inhibitors

Jan. 8, 2018

Northwestern University describes novel nitric oxide synthase inhibitors

Jan. 8, 2018

Novel KDM5B inhibitors described in Chrysalis patent

Jan. 5, 2018

BioMarin Pharmaceutical presents novel CGT inhibitors

Jan. 5, 2018

Roche discloses new TLR8 agonists

Jan. 5, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...